HumanKindLabs catalyses psychedelic clinical research on set & setting and brings optimised treatment protocols into society. HumanKindLabs offers advisory services to researchers seeking to procure GMP grade psychedelic compounds for clinical trials.
The Swedish Network for Psychedelic Science (NPV) is a non-profit member association with the purpose of promoting research on psychedelics. The association has over 1000 members and organizes lectures and seminars related to psychedelic science.
PAREA is a non-profit, multistakeholder and multidisciplinary partnership, and Norrsken Mind is one of its Founding Members. By combining and streamlining the knowledge and expertise of its members, PAREA brings comprehensive advice and guidance to EU policymakers – whilst delivering value to society in the process.
Usona Institute is a 501(c)(3) non-profit medical research organization based in Madison, Wisconsin. Usona is dedicated to supporting and conducting pre-clinical and clinical research to further the understanding of the therapeutic effects of psilocybin and other psychedelics. Norrsken Mind is collaborating with Usona to provide qualified researchers with pharmaceutical-grade psilocybin.
WONSA is a Swedish fundraising foundation that works for a world without sexual abuse. Since 2018, Wonsa runs Sweden's only research-oriented specialist clinic for adults who have been subjected to sexual abuse in childhood.
Hyper One creates and develops initiatives within health, technology and education with a focus on making a difference in the world around us. As an investor and strategic partner, through Hyper One and its subsidiary 0+X, Hyper One help entrepreneurs and companies realize their ideas by adding technical expertise, creativity and competence from all over the world.
Niklas Adalberth, Founder of Norrsken Foundation
Albert Hobohm, Huxley Foundation
Jonas Nordlander & Kina Zeidler